# SABRIL
> **NDA020427** · New Drug Application · Sponsor: LUNDBECK PHARMS LLC · Approved 2009-08-21
## Drug
- **FDA Application Number:** NDA020427
- **Application type:** New Drug Application
- **Brand name:** SABRIL
- **Generic name:** VIGABATRIN
- **Active ingredients:** VIGABATRIN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** LUNDBECK PHARMS LLC
- **Manufacturer:** Lundbeck Pharmaceuticals LLC
- **First approval:** 2009-08-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020427)
---
*MORVS · CC0 1.0*